Comment on: “Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases”

Detalles Bibliográficos
Autores principales: Woolcott, John, Cappelleri, Joseph C., Sharma, Puza, Modesto, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140735/
https://www.ncbi.nlm.nih.gov/pubmed/32173793
http://dx.doi.org/10.1007/s12325-020-01268-3
_version_ 1783519058611666944
author Woolcott, John
Cappelleri, Joseph C.
Sharma, Puza
Modesto, Irene
author_facet Woolcott, John
Cappelleri, Joseph C.
Sharma, Puza
Modesto, Irene
author_sort Woolcott, John
collection PubMed
description
format Online
Article
Text
id pubmed-7140735
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-71407352020-04-14 Comment on: “Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases” Woolcott, John Cappelleri, Joseph C. Sharma, Puza Modesto, Irene Adv Ther Letter Springer Healthcare 2020-03-15 2020 /pmc/articles/PMC7140735/ /pubmed/32173793 http://dx.doi.org/10.1007/s12325-020-01268-3 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Woolcott, John
Cappelleri, Joseph C.
Sharma, Puza
Modesto, Irene
Comment on: “Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases”
title Comment on: “Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases”
title_full Comment on: “Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases”
title_fullStr Comment on: “Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases”
title_full_unstemmed Comment on: “Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases”
title_short Comment on: “Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases”
title_sort comment on: “retrospective claims analysis indirectly comparing medication adherence and persistence between intravenous biologics and oral small-molecule therapies in inflammatory bowel diseases”
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140735/
https://www.ncbi.nlm.nih.gov/pubmed/32173793
http://dx.doi.org/10.1007/s12325-020-01268-3
work_keys_str_mv AT woolcottjohn commentonretrospectiveclaimsanalysisindirectlycomparingmedicationadherenceandpersistencebetweenintravenousbiologicsandoralsmallmoleculetherapiesininflammatoryboweldiseases
AT cappellerijosephc commentonretrospectiveclaimsanalysisindirectlycomparingmedicationadherenceandpersistencebetweenintravenousbiologicsandoralsmallmoleculetherapiesininflammatoryboweldiseases
AT sharmapuza commentonretrospectiveclaimsanalysisindirectlycomparingmedicationadherenceandpersistencebetweenintravenousbiologicsandoralsmallmoleculetherapiesininflammatoryboweldiseases
AT modestoirene commentonretrospectiveclaimsanalysisindirectlycomparingmedicationadherenceandpersistencebetweenintravenousbiologicsandoralsmallmoleculetherapiesininflammatoryboweldiseases

Ejemplares similares